Report Detail

Request for Sample of this report

Pharma & Healthcare Global Human Rabies Vaccine Supply, Demand and Key Producers, 2026-2032

  • RnM4667096
    • |
  • 22 January, 2026
    • |
  • Global
    • |
  • 135 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

The global Human Rabies Vaccine market size is expected to reach $ 1631 million by 2032, rising at a market growth of 4.2% CAGR during the forecast period (2026-2032).
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
The increasing awareness of rabies prevention and the rising number of reported cases of animal bites, particularly in developing countries, are key drivers of the human rabies vaccine market. Government-led vaccination programs, international health initiatives, and educational campaigns have significantly boosted demand for pre- and post-exposure prophylaxis, including human rabies vaccines. Moreover, improvements in vaccine technology, such as the development of safer and more effective vaccines, are also contributing to the growth of the market.
One major challenge in the human rabies vaccine market is the uneven access to vaccines, especially in regions where rabies is endemic. High costs, cold chain requirements for storage, and distribution challenges in rural or underdeveloped areas make it difficult for healthcare providers to ensure timely vaccination. Additionally, a lack of healthcare infrastructure and trained personnel to administer the vaccine can hinder its effectiveness in regions most affected by rabies, limiting the overall impact of vaccination efforts.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share. Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
This report studies the global Human Rabies Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Rabies Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Rabies Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Rabies Vaccine total production and demand, 2021-2032, (K Units)
Global Human Rabies Vaccine total production value, 2021-2032, (USD Million)
Global Human Rabies Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Human Rabies Vaccine consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Human Rabies Vaccine domestic production, consumption, key domestic manufacturers and share
Global Human Rabies Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Human Rabies Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Human Rabies Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Human Rabies Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Rabies Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Human Rabies Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Human Rabies Vaccine Market, Segmentation by Type:
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Global Human Rabies Vaccine Market, Segmentation by Application:
Pre-Exposure Vaccine
Post-Exposure Vaccine
Companies Profiled:
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Key Questions Answered:
1. How big is the global Human Rabies Vaccine market?
2. What is the demand of the global Human Rabies Vaccine market?
3. What is the year over year growth of the global Human Rabies Vaccine market?
4. What is the production and production value of the global Human Rabies Vaccine market?
5. Who are the key producers in the global Human Rabies Vaccine market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 Human Rabies Vaccine Introduction
  • 1.2 World Human Rabies Vaccine Supply & Forecast
    • 1.2.1 World Human Rabies Vaccine Production Value (2021 & 2025 & 2032)
    • 1.2.2 World Human Rabies Vaccine Production (2021-2032)
    • 1.2.3 World Human Rabies Vaccine Pricing Trends (2021-2032)
  • 1.3 World Human Rabies Vaccine Production by Region (Based on Production Site)
    • 1.3.1 World Human Rabies Vaccine Production Value by Region (2021-2032)
    • 1.3.2 World Human Rabies Vaccine Production by Region (2021-2032)
    • 1.3.3 World Human Rabies Vaccine Average Price by Region (2021-2032)
    • 1.3.4 North America Human Rabies Vaccine Production (2021-2032)
    • 1.3.5 Europe Human Rabies Vaccine Production (2021-2032)
    • 1.3.6 China Human Rabies Vaccine Production (2021-2032)
    • 1.3.7 India Human Rabies Vaccine Production (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Human Rabies Vaccine Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Human Rabies Vaccine Major Market Trends

2 Demand Summary

  • 2.1 World Human Rabies Vaccine Demand (2021-2032)
  • 2.2 World Human Rabies Vaccine Consumption by Region
    • 2.2.1 World Human Rabies Vaccine Consumption by Region (2021-2026)
    • 2.2.2 World Human Rabies Vaccine Consumption Forecast by Region (2027-2032)
  • 2.3 United States Human Rabies Vaccine Consumption (2021-2032)
  • 2.4 China Human Rabies Vaccine Consumption (2021-2032)
  • 2.5 Europe Human Rabies Vaccine Consumption (2021-2032)
  • 2.6 Japan Human Rabies Vaccine Consumption (2021-2032)
  • 2.7 South Korea Human Rabies Vaccine Consumption (2021-2032)
  • 2.8 ASEAN Human Rabies Vaccine Consumption (2021-2032)
  • 2.9 India Human Rabies Vaccine Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

  • 3.1 World Human Rabies Vaccine Production Value by Manufacturer (2021-2026)
  • 3.2 World Human Rabies Vaccine Production by Manufacturer (2021-2026)
  • 3.3 World Human Rabies Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Human Rabies Vaccine Company Evaluation Quadrant
  • 3.5 Industry Rank and Concentration Rate (CR)
    • 3.5.1 Global Human Rabies Vaccine Industry Rank of Major Manufacturers
    • 3.5.2 Global Concentration Ratios (CR4) for Human Rabies Vaccine in 2025
    • 3.5.3 Global Concentration Ratios (CR8) for Human Rabies Vaccine in 2025
  • 3.6 Human Rabies Vaccine Market: Overall Company Footprint Analysis
    • 3.6.1 Human Rabies Vaccine Market: Region Footprint
    • 3.6.2 Human Rabies Vaccine Market: Company Product Type Footprint
    • 3.6.3 Human Rabies Vaccine Market: Company Product Application Footprint
  • 3.7 Competitive Environment
    • 3.7.1 Historical Structure of the Industry
    • 3.7.2 Barriers of Market Entry
    • 3.7.3 Factors of Competition
  • 3.8 New Entrant and Capacity Expansion Plans
  • 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

  • 4.1 United States VS China: Human Rabies Vaccine Production Value Comparison
    • 4.1.1 United States VS China: Human Rabies Vaccine Production Value Comparison (2021 & 2025 & 2032)
    • 4.1.2 United States VS China: Human Rabies Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States VS China: Human Rabies Vaccine Production Comparison
    • 4.2.1 United States VS China: Human Rabies Vaccine Production Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Human Rabies Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States VS China: Human Rabies Vaccine Consumption Comparison
    • 4.3.1 United States VS China: Human Rabies Vaccine Consumption Comparison (2021 & 2025 & 2032)
    • 4.3.2 United States VS China: Human Rabies Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
  • 4.4 United States Based Human Rabies Vaccine Manufacturers and Market Share, 2021-2026
    • 4.4.1 United States Based Human Rabies Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    • 4.4.2 United States Based Manufacturers Human Rabies Vaccine Production Value (2021-2026)
    • 4.4.3 United States Based Manufacturers Human Rabies Vaccine Production (2021-2026)
  • 4.5 China Based Human Rabies Vaccine Manufacturers and Market Share
    • 4.5.1 China Based Human Rabies Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    • 4.5.2 China Based Manufacturers Human Rabies Vaccine Production Value (2021-2026)
    • 4.5.3 China Based Manufacturers Human Rabies Vaccine Production (2021-2026)
  • 4.6 Rest of World Based Human Rabies Vaccine Manufacturers and Market Share, 2021-2026
    • 4.6.1 Rest of World Based Human Rabies Vaccine Manufacturers, Headquarters and Production Site (State, Country)
    • 4.6.2 Rest of World Based Manufacturers Human Rabies Vaccine Production Value (2021-2026)
    • 4.6.3 Rest of World Based Manufacturers Human Rabies Vaccine Production (2021-2026)

5 Market Analysis by Type

  • 5.1 World Human Rabies Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Vero Cell
    • 5.2.2 BHK
    • 5.2.3 Chick Embryo Cell
    • 5.2.4 Human Diploid Cells
    • 5.2.5 Others
  • 5.3 Market Segment by Type
    • 5.3.1 World Human Rabies Vaccine Production by Type (2021-2032)
    • 5.3.2 World Human Rabies Vaccine Production Value by Type (2021-2032)
    • 5.3.3 World Human Rabies Vaccine Average Price by Type (2021-2032)

6 Market Analysis by Application

  • 6.1 World Human Rabies Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Pre-Exposure Vaccine
    • 6.2.2 Post-Exposure Vaccine
  • 6.3 Market Segment by Application
    • 6.3.1 World Human Rabies Vaccine Production by Application (2021-2032)
    • 6.3.2 World Human Rabies Vaccine Production Value by Application (2021-2032)
    • 6.3.3 World Human Rabies Vaccine Average Price by Application (2021-2032)

7 Company Profiles

  • 7.1 Bharat Biotech
    • 7.1.1 Bharat Biotech Details
    • 7.1.2 Bharat Biotech Major Business
    • 7.1.3 Bharat Biotech Human Rabies Vaccine Product and Services
    • 7.1.4 Bharat Biotech Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Bharat Biotech Recent Developments/Updates
    • 7.1.6 Bharat Biotech Competitive Strengths & Weaknesses
  • 7.2 Bavarian Nordic
    • 7.2.1 Bavarian Nordic Details
    • 7.2.2 Bavarian Nordic Major Business
    • 7.2.3 Bavarian Nordic Human Rabies Vaccine Product and Services
    • 7.2.4 Bavarian Nordic Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Bavarian Nordic Recent Developments/Updates
    • 7.2.6 Bavarian Nordic Competitive Strengths & Weaknesses
  • 7.3 Sanofi-Pasteur
    • 7.3.1 Sanofi-Pasteur Details
    • 7.3.2 Sanofi-Pasteur Major Business
    • 7.3.3 Sanofi-Pasteur Human Rabies Vaccine Product and Services
    • 7.3.4 Sanofi-Pasteur Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Sanofi-Pasteur Recent Developments/Updates
    • 7.3.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
  • 7.4 Chengda Bio
    • 7.4.1 Chengda Bio Details
    • 7.4.2 Chengda Bio Major Business
    • 7.4.3 Chengda Bio Human Rabies Vaccine Product and Services
    • 7.4.4 Chengda Bio Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Chengda Bio Recent Developments/Updates
    • 7.4.6 Chengda Bio Competitive Strengths & Weaknesses
  • 7.5 KANGH
    • 7.5.1 KANGH Details
    • 7.5.2 KANGH Major Business
    • 7.5.3 KANGH Human Rabies Vaccine Product and Services
    • 7.5.4 KANGH Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.5.5 KANGH Recent Developments/Updates
    • 7.5.6 KANGH Competitive Strengths & Weaknesses
  • 7.6 Prcmise
    • 7.6.1 Prcmise Details
    • 7.6.2 Prcmise Major Business
    • 7.6.3 Prcmise Human Rabies Vaccine Product and Services
    • 7.6.4 Prcmise Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Prcmise Recent Developments/Updates
    • 7.6.6 Prcmise Competitive Strengths & Weaknesses
  • 7.7 Henan Grand Biopharma
    • 7.7.1 Henan Grand Biopharma Details
    • 7.7.2 Henan Grand Biopharma Major Business
    • 7.7.3 Henan Grand Biopharma Human Rabies Vaccine Product and Services
    • 7.7.4 Henan Grand Biopharma Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.7.5 Henan Grand Biopharma Recent Developments/Updates
    • 7.7.6 Henan Grand Biopharma Competitive Strengths & Weaknesses
  • 7.8 Zhuoyi Biological
    • 7.8.1 Zhuoyi Biological Details
    • 7.8.2 Zhuoyi Biological Major Business
    • 7.8.3 Zhuoyi Biological Human Rabies Vaccine Product and Services
    • 7.8.4 Zhuoyi Biological Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.8.5 Zhuoyi Biological Recent Developments/Updates
    • 7.8.6 Zhuoyi Biological Competitive Strengths & Weaknesses
  • 7.9 ZhongKe Biopharm
    • 7.9.1 ZhongKe Biopharm Details
    • 7.9.2 ZhongKe Biopharm Major Business
    • 7.9.3 ZhongKe Biopharm Human Rabies Vaccine Product and Services
    • 7.9.4 ZhongKe Biopharm Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.9.5 ZhongKe Biopharm Recent Developments/Updates
    • 7.9.6 ZhongKe Biopharm Competitive Strengths & Weaknesses
  • 7.10 Ningbo Rongan Biological
    • 7.10.1 Ningbo Rongan Biological Details
    • 7.10.2 Ningbo Rongan Biological Major Business
    • 7.10.3 Ningbo Rongan Biological Human Rabies Vaccine Product and Services
    • 7.10.4 Ningbo Rongan Biological Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Ningbo Rongan Biological Recent Developments/Updates
    • 7.10.6 Ningbo Rongan Biological Competitive Strengths & Weaknesses
  • 7.11 Indian Immunologicals
    • 7.11.1 Indian Immunologicals Details
    • 7.11.2 Indian Immunologicals Major Business
    • 7.11.3 Indian Immunologicals Human Rabies Vaccine Product and Services
    • 7.11.4 Indian Immunologicals Human Rabies Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.11.5 Indian Immunologicals Recent Developments/Updates
    • 7.11.6 Indian Immunologicals Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Human Rabies Vaccine Industry Chain
  • 8.2 Human Rabies Vaccine Upstream Analysis
    • 8.2.1 Human Rabies Vaccine Core Raw Materials
    • 8.2.2 Main Manufacturers of Human Rabies Vaccine Core Raw Materials
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis
  • 8.5 Human Rabies Vaccine Production Mode
  • 8.6 Human Rabies Vaccine Procurement Model
  • 8.7 Human Rabies Vaccine Industry Sales Model and Sales Channels
    • 8.7.1 Human Rabies Vaccine Sales Model
    • 8.7.2 Human Rabies Vaccine Typical Distributors

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Human Rabies Vaccine. Industry analysis & Market Report on Human Rabies Vaccine is a syndicated market report, published as Global Human Rabies Vaccine Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Human Rabies Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,480.00
    		$6,720.00
    		$8,960.00
    		3,463.04
    		5,194.56
    		6,926.08
    		4,170.88
    		6,256.32
    		8,341.76
    		684,051.20
    		1,026,076.80
    		1,368,102.40
    		378,112.00
    		567,168.00
    		756,224.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo